- This event has passed.
Going Public – Biotech Leaders On their Path To Funding
April 24 @ 5:00 pm - 7:00 pm
Leaders of New Jersey’s publicly traded biotech firms will tell their story and provide guidance and recommendations on going public as a path to funding.
Register now and join us for networking and guidance from Scott Jackson, past CEO of Celator recently acquired by Jazz Pharmaceuticals, and Dan O’Connor, CEO of Advaxis and Kathleen Bloch, CFO of Cytosorbents.
The panel will showcase biotech leaders on their respective paths to success, including insights into their strategy and decisions faced along the way to their companies becoming public.